In summary, our results indicate that local Ang II production and/or action is likely not contributing to development of cardiac hypertrophy in early stages of hypertension development and, instead, the reduction in afterload following losartan appears to be the pivotal factor. The gene discussed is AGT; the disease is cardiac hypertrophy.